Jane Wheeler is currently the Medical Director of Business Development and Early Assets for APAC at CSL Seqirus, where they lead medical evaluation and strategic planning for early assets in the pharmaceutical and vaccine sectors. Their extensive background in the pharmaceutical industry includes roles at organizations such as Bristol-Myers Squibb, GSK, Seqirus, and MSD, where they have demonstrated expertise in medical affairs, business development, and strategic planning across multiple therapy areas. Jane has developed strong partnerships within the industry and academia globally, showcasing innovative projects in immuno-oncology and spearheading various medical education initiatives. They hold a Bachelor of Pharmacy with Honors from Monash University and continue to enhance their knowledge in the field.
This person is not in the org chart
This person is not in any teams
This person is not in any offices